Attention-Deficit/Hyperactivity Disorder Medication Prescription Claims Among Privately Insured Women Aged 15–44 Years — United States, 2003–2015
Year: 2018
Type: article
Study design: Observational Study
Abstract: Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that affects individuals across the lifespan.ADHD medication use among pregnant women is increasing (1), but consensus about the safety of ADHD medication use during pregnancy is lacking.Given that nearly half of U.S. pregnancies are unintended (2), and early pregnancy is a critical period for fetal development, examining trends in ADHD medication prescriptions among reproductive-aged women is important to quantify the population at risk for potential exposure.CDC used the Truven Health MarketScan Commercial Database* for the period 2003-2015 to estimate the percentage of women aged 15-44 years with private employer-sponsored insurance who filled prescriptions for ADHD medications each year.The percentage of reproductive-aged women who filled at least one ADHD medication prescription increased 344% from 2003 (0.9% of women) to 2015 (4.0% of women).In 2015, the most frequently filled medications were mixed amphetamine salts, lisdexamfetamine, and methylphenidate.Prescribing ADHD medications to reproductive-aged women is increasingly common; additional research on ADHD medication safety during pregnancy is warranted to inform women and their health care providers about any potential risks associated with ADHD medication exposure before and during pregnancy.CDC used the Truven Health MarketScan Commercial Database to examine outpatient pharmacy prescription drug claims for ADHD medications among reproductive-aged (15-44 years) women during 2003-2015.These data represent a convenience sample of persons with private employersponsored insurance and their dependents in the United States.Demographic data are available for all persons enrolled at any point during the year, regardless of whether a claim is filed, and are linkable to submitted outpatient pharmacy claims.This analysis was restricted to women aged 15-44 years with ≥11 months of enrollment in a private health insurance plan that included prescription drug coverage during the year of interest.Outpatient pharmacy claims for ADHD medications were identified using national drug codes, irrespective of the indication for use.Data were analyzed to assess the annual percentage of reproductive-aged women who filled any ADHD * Truven Health Analytics, Atlanta, Georgia.
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2782999578
